Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
PLoS One
; 13(2): e0192717, 2018.
Article
in En
| MEDLINE
| ID: mdl-29438386
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Malaria, Cerebral
/
Doxycycline
/
Antimalarials
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2018
Document type:
Article
Affiliation country:
Germany
Country of publication:
United States